TLR3 activation enhances sorafenib-antitumor effect in hepatocellular carcinoma by activating NK cell functions through ERK and NF-κB pathwaysQiangbo Zhang(Shandong University), Enyu Liu(Shandong University)Research SquareApril 8, 202410.21203/rs.3.rs-4124175/v1Cited by 0SaveCiteExport RISWatch citationsRelated PapersSuppression of Natural Killer Cells by Sorafenib Contributes to Prometastatic Effects in Hepatocellular Carcinoma|PLoS ONE|2013|60TLR3 activation enhances antitumor effects of sorafenib in hepatocellular carcinoma by activating NK cell functions through ERK and NF-κB pathways|Scientific Reports|2024|2